We can expect the cosmetics and food industry accounts to expand. We should view that part of the NanoLogix tech as the initial "bread and butter" operating base and I then expect the upcoming N-Assay technology to expand sales significantly. The funny thing is that I was talking to a knowledgeable source last week and was told, "as soon as the company posts improving financials, there will be someone who says "but they really needed to earn (blah, blah)". The reality is that the "you know who's" have a steady arsenal of complaints that they post to try to undermine any good news. We have a company with growing sales, a critical technology about to be granted a patent, the real probability of an expanded market into which to sell shares, and we should be pleased with these developments. Merry Christmas. As I said yesterday, I just bought 40,000 shares at what I consider to be an incredibly great price over the past week and now I am thinking of more.